However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
They are not intended for human consumption, clinical use, therapeutic application, diagnosis, treatment, cure, or prevention of any disease
This decline accelerates during caloric restriction, making the deficit state particularly catabolic
References to research reflect published literature and do not constitute an endorsement of any specific therapeutic use
Once reconstituted with bacteriostatic water, vials must be kept refrigerated between 2C and 8C
